China Universal Asset Management Co., Ltd. Recursion Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 79,245 shares of RXRX stock, worth $362,149. This represents 0.04% of its overall portfolio holdings.
Number of Shares
79,245
Previous 80,943
2.1%
Holding current value
$362,149
Previous $547,000
23.4%
% of portfolio
0.04%
Previous 0.05%
Shares
16 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$159 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$148 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$111 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$79.1 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$67 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $825M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...